Home » Newsletters » BioWorld Science

BioWorld Science

May 22, 2009

View Archived Issues

Anti-cathepsin S monoclonal antibody developed by Fusion Antibodies for cancer immunotherapy

VaxInnate's recombinant hemagglutinin influenza vaccines safe and immunogenic in healthy adults

AS-703026, a novel allosteric inhibitor of MEK, displays potent preclinical antitumor activity

IT-101 regimens compared in patients with refractory solid tumors

LTX-109 shows low propensity for in vitro resistance development in S. aureus isolates

Copper/AAV-based gene therapy increases survival in model of Menkes disease / News in Context

Boston Scientific launches Taxus Element paclitaxel-eluting coronary stent

Solvay signs partnership agreement with Huya Bioscience for access to Chinese molecule portfolio

Amgen describes p38alpha MAPK modulators for the treatment of inflammation

Phase II data on Lu-AA-21004 in depression presented, product advances to phase III

Millennium Pharmaceuticals claims proteasome inhibitors for cancer treatment

Long-acting octreotide improves cystoid maculopathy in some patients

Post-hoc data show no role for gemfibrozil in atrial fibrillation in coronary heart disease subjects

Effects of lutein supplementation in age-related macular degeneration evaluated in the EMPOLS study

Pixantrone trial shows minimal cardiac effects despite doxorubicin treatment

Santhera's phase III IONIA Trial in Friedreich's ataxia misses primary endpoint

Argenta Discovery extends major drug discovery collaboration with Genentech

Enobia's ENB-0040 receives FDA fast track designation

IntelGenx and Circ Pharma to commence proof-of-concept study of CRES pravastatin

Sucampo initiates pivotal Japanese phase III lubiprostone trial in idiopathic constipation

Bionomics to initiate human clinical trial of anxiety drug BNC-210 in Australia

Medtronic and Lilly sign marketing collaboration to provide education on diabetes

Merck & Co. to launch Tredaptive/Cordaptive in international markets in 2009

Mitsubishi Tanabe Pharma obtains approval in Japan for additional indication for Valixa

Novel tyrosine kinase inhibitors for cancer treatment discovered by Janssen

Lilly advances second Alzheimer's candidate into late-stage clinical testing

European Commission approves Qutenza for peripheral neuropathic pain

FDA approves Otsuka's Samsca for hypervolemic and euvolemic hyponatremia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...